In the 3 years since residual gadolinium-based contrast agent (GBCA) in the brain was first reported, much has been learned about its accumulation, including the pathway of GBCA entry into the brain, the brain distribution of GBCA and its excretion. Here we review recent progress in understanding the routes of gadolinium deposition in brain structures.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963376PMC
http://dx.doi.org/10.1259/bjr.20170115DOI Listing

Publication Analysis

Top Keywords

brain
5
distribution chemical
4
chemical forms
4
forms gadolinium
4
gadolinium brain
4
brain review
4
review years
4
years residual
4
residual gadolinium-based
4
gadolinium-based contrast
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!